Floxuridine Hepatic Arterial Infusion Associated Biliary Toxicity Is Increased by Concurrent Administration of Systemic Bevacizumab
作者： Andrea Cercek , Michael D’Angelica , Derek Power , Marinela Capanu , Alexandra Gewirtz
DOI: 10.1245/S10434-013-3275-0
关键词:
摘要: Purpose Systemic bevacizumab (Bev) was added to hepatic arterial infusion (HAI) floxuridine (FUDR)-based chemotherapy in three studies an attempt improve outcomes. A specific review of biliary toxicity carried out.
springer.com
sci-hub.se 参考文章(39)
William D. Ensminger, Steven Come, Emil Frei, Glenn Steele, Michael Glode, Vic Raso, Andre Rosowsky, David C. Levin, A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil. Cancer Research. ,vol. 38, pp. 3784- 3792 ,(1978)
Kaori Ito, Hiromichi Ito, Nancy E. Kemeny, Mithat Gonen, Peter J. Allen, Philip B. Paty, Yuman Fong, Ronald P. DeMatteo, Leslie H. Blumgart, William R. Jarnagin, Michael I. D’Angelica, Biliary sclerosis after hepatic arterial infusion pump chemotherapy for patients with colorectal cancer liver metastasis: incidence, clinical features, and risk factors. Annals of Surgical Oncology. ,vol. 19, pp. 1609- 1617 ,(2012) , 10.1245/S10434-011-2102-8
Nancy E. Kemeny, Lawrence Schwartz, Mithat Gönen, Adam Yopp, David Gultekin, Michael I. D’Angelica, Yuman Fong, Dana Haviland, Alexandra N. Gewirtz, Peter Allen, William R. Jarnagin, Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: does the addition of systemic bevacizumab improve results? Oncology. ,vol. 80, pp. 153- 159 ,(2011) , 10.1159/000324704
J. M. A. Northover, John Terblanche, A new look at the arterial supply of the bile duct in man and its surgical implications. British Journal of Surgery. ,vol. 66, pp. 379- 384 ,(2005) , 10.1002/BJS.1800660603
Laurie D. DeLeve, Xiangdong Wang, Liping Hu, Margaret K. McCuskey, Robert S. McCuskey, Rat liver sinusoidal endothelial cell phenotype is maintained by paracrine and autocrine regulation. American Journal of Physiology-gastrointestinal and Liver Physiology. ,vol. 287, ,(2004) , 10.1152/AJPGI.00017.2004
N. Kemeny, W. Jarnagin, M. Gonen, J. Stockman, L. Blumgart, D. Sperber, A. Hummer, Y. Fong, Phase I/II Study of Hepatic Arterial Therapy With Floxuridine and Dexamethasone in Combination With Intravenous Irinotecan As Adjuvant Treatment After Resection of Hepatic Metastases From Colorectal Cancer Journal of Clinical Oncology. ,vol. 21, pp. 3303- 3309 ,(2003) , 10.1200/JCO.2003.03.142
Nancy Kemeny, Ying Huang, Alfred M. Cohen, Weiji Shi, John A. Conti, Murray F. Brennan, Joseph R. Bertino, Alan D.M. Turnbull, Deidre Sullivan, Jennifer Stockman, Leslie H. Blumgart, Yuman Fong, Hepatic Arterial Infusion of Chemotherapy after Resection of Hepatic Metastases from Colorectal Cancer New England Journal of Medicine. ,vol. 341, pp. 2039- 2048 ,(1999) , 10.1056/NEJM199912303412702
Diane Goéré, Isabelle Deshaies, Thierry de Baere, Valérie Boige, David Malka, Frédéric Dumont, Clarisse Dromain, Michel Ducreux, Dominique Elias, Prolonged Survival of Initially Unresectable Hepatic Colorectal Cancer Patients Treated With Hepatic Arterial Infusion of Oxaliplatin Followed by Radical Surgery of Metastases Annals of Surgery. ,vol. 251, pp. 686- 691 ,(2010) , 10.1097/SLA.0B013E3181D35983
Zhao-Shi Zeng, Zuo-Feng Zhang, E.R. Sigurdson, Toxicity study of hepatic artery infusion chemotherapy with massive dose FUDR in rats. Surgical Oncology-oxford. ,vol. 4, pp. 147- 155 ,(1995) , 10.1016/S0960-7404(10)80019-2
R. K. Jain, Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy Science. ,vol. 307, pp. 58- 62 ,(2005) , 10.1126/SCIENCE.1104819